Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1991; Volume 39,Issue 3
  • You have access
    Noncompetitive inhibition of gamma-aminobutyric acidA channels by Zn.
    P Legendre and G L Westbrook
    Molecular Pharmacology March 1991, 39 (3) 267-274;
  • You have access
    Induction of cytochrome P450IIE1 in the obese overfed rat.
    J L Raucy, J M Lasker, J C Kraner, D E Salazar, C S Lieber and G B Corcoran
    Molecular Pharmacology March 1991, 39 (3) 275-280;
  • You have access
    Inhibition of cell colony formation by selenite: involvement of glutathione.
    P B Caffrey and G D Frenkel
    Molecular Pharmacology March 1991, 39 (3) 281-284;
  • You have access
    Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.
    C E Dusenbury, M A Davis, T S Lawrence and J Maybaum
    Molecular Pharmacology March 1991, 39 (3) 285-289;
  • You have access
    Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
    K M Standifer, L R Murthy, K Kinouchi, L Steele and G W Pasternak
    Molecular Pharmacology March 1991, 39 (3) 290-298;
  • You have access
    Selective inhibition of sequence-specific protein-DNA interactions by incorporation of 6-thioguanine: cleavage by restriction endonucleases.
    L M Iwaniec, J J Kroll, W M Roethel and J Maybaum
    Molecular Pharmacology March 1991, 39 (3) 299-306;
  • You have access
    Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor.
    F H Lin, G Clark, L S Birnbaum, G W Lucier and J A Goldstein
    Molecular Pharmacology March 1991, 39 (3) 307-313;
  • You have access
    Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.
    J Huwyler, M Bürgin, T Zeugin and J Gut
    Molecular Pharmacology March 1991, 39 (3) 314-323;
  • You have access
    Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures.
    M Quik, H el-Bizri, T Audhya and G Goldstein
    Molecular Pharmacology March 1991, 39 (3) 324-331;
  • You have access
    Short chain and long chain alkanols have different sites of action on nicotinic acetylcholine receptor channels from Torpedo.
    S C Wood, S A Forman and K W Miller
    Molecular Pharmacology March 1991, 39 (3) 332-338;
  • You have access
    Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
    J W Boja, M A Rahman, A Philip, A H Lewin, F I Carroll and M J Kuhar
    Molecular Pharmacology March 1991, 39 (3) 339-345;
  • You have access
    Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    C W Lin, K Shiosaki, T R Miller, D G Witte, B R Bianchi, C A Wolfram, H Kopecka, R Craig, F Wagenaar and A M Nadzan
    Molecular Pharmacology March 1991, 39 (3) 346-351;
  • You have access
    Block of single batrachotoxin-activated Na+ channels by clofilium.
    J Nettleton, N A Castle and G K Wang
    Molecular Pharmacology March 1991, 39 (3) 352-358;
  • You have access
    Carbachol activates a novel sodium current in isolated guinea pig ventricular myocytes via M2 muscarinic receptors.
    K Matsumoto and A J Pappano
    Molecular Pharmacology March 1991, 39 (3) 359-363;
  • You have access
    Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
    R Y Kanterman, L C Mahan, E M Briley, F J Monsma, D R Sibley, J Axelrod and C C Felder
    Molecular Pharmacology March 1991, 39 (3) 364-369;
  • You have access
    cAMP analogs inhibit gamma-aminobutyric acid-gated chloride flux and activate protein kinase A in brain synaptoneurosomes.
    R D Schwartz, G Heuschneider, P P Edgar and J A Cohn
    Molecular Pharmacology March 1991, 39 (3) 370-375;
  • You have access
    Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    T J Torphy, H L Zhou, M Burman and L B Huang
    Molecular Pharmacology March 1991, 39 (3) 376-384;
  • You have access
    Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Y Itzhak, D Mash, S H Zhang and I Stein
    Molecular Pharmacology March 1991, 39 (3) 385-393;
  • You have access
    Correlation between gamma-aminobutyric acidA receptor ligand-induced changes in t-butylbicyclophosphoro[35S]thionate binding and 36Cl- uptake in rat cerebrocortical membranes.
    W B Im and D P Blakeman
    Molecular Pharmacology March 1991, 39 (3) 394-398;
  • You have access
    Serum-induced sensitization of cyclic AMP accumulation in 1321N1 human astrocytoma cells.
    R A Johnson, L J Arneson-Rotert, J M Hoffman and M L Toews
    Molecular Pharmacology March 1991, 39 (3) 399-406;
  • You have access
    Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors.
    K Klijn, S R Slivka, K Bell and P A Insel
    Molecular Pharmacology March 1991, 39 (3) 407-413;
  • You have access
    Futile cycling of a sulfate conjugate by isolated hepatocytes.
    F C Kauffman, M Whittaker, I Anundi and R G Thurman
    Molecular Pharmacology March 1991, 39 (3) 414-420;
  • You have access
    Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    C S Murphy, C J Parker, R McCague and V C Jordan
    Molecular Pharmacology March 1991, 39 (3) 421-428;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 39, Issue 3
1 Mar 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics